April 24th, 2026
FDA Fast-Tracks Psychedelic-Based Mental Health Treatments as Aging America Faces Rising Long-Term Care Risk
Federal regulators are accelerating psychedelic-based mental health treatments for serious conditions. Many veterans, researchers, and patient advocates applauded the move as a long-overdue, bipartisan step to address the mental health crisis, including major depressive disorder in older adults.